Second $20m loan for StemCells Inc alongside Capricor's first under California stem cell programme
This article was originally published in Scrip
Executive Summary
The California Institute of Regenerative Medicine (CIRM) has approved its second round of "disease team" awards, which included two separate $20 million loans to cardiac stem cell specialist Capricor and StemCells Inc, which won a second loan to develop its purified human neural stem cells (HuCNS-SC).